Keep an Eye on At-Home Devices: Energy-Based Acne and Anti-Aging Devices are Associated with Ocular Adverse Events in a Retrospective Analysis Using the MAUDE Database

Keep an Eye on At-Home Devices: Energy-Based Acne and Anti-Aging Devices are Associated with Ocular Adverse Events in a Retrospective Analysis Using the MAUDE Database

Authors

  • Rachel C Hill Weill Cornell Medical College, New York, NY
  • Shari R Lipner Weill Cornell Medicine, Department of Dermatology, New York, NY

Keywords:

acne, photoaging, MAUDE, medical device report, adverse events

References

Juhász ML, Levin MK, Marmur ES. A review of available laser and intense light source home devices: A dermatologist's perspective. J Cosmet Dermatol. 2017;16(4):438-443. doi:10.1111/jocd.12371

Kayıran MA, Karadağ AS, Alyamaç G, et al. Use of Complementary and Alternative Medicine among Patients with Acne Vulgaris and Factors Perceived to Trigger the Disease: A Multicentre Cross-Sectional Study with 1571 Patients. Indian J Dermatol. 2022;67(3):311. doi:10.4103/ijd.ijd_745_21

Hession MT, Markova A, Graber EM. A review of hand-held, home-use cosmetic laser and light devices. Dermatol Surg. 2015;41(3):307-320. doi:10.1097/DSS.0000000000000283

Cohen M, Austin E, Masub N, Kurtti A, George C, Jagdeo J. Home-based devices in dermatology: a systematic review of safety and efficacy. Arch Dermatol Res. 2022;314(3):239-246. doi:10.1007/s00403-021-02231-0

Sadick NS. A study to determine the efficacy of a novel handheld light-emitting diode device in the treatment of photoaged skin. J Cosmet Dermatol. 2008;7(4):263-267. doi:10.1111/j.1473-2165.2008.00404.x

Downloads

Published

2024-07-31

Issue

Section

Letter to the Editor

How to Cite

1.
Keep an Eye on At-Home Devices: Energy-Based Acne and Anti-Aging Devices are Associated with Ocular Adverse Events in a Retrospective Analysis Using the MAUDE Database. Dermatol Pract Concept [Internet]. 2024 Jul. 31 [cited 2024 Dec. 5];14(3):e2024174. Available from: https://www.dpcj.org/index.php/dpc/article/view/4130

Share